| K-number | K242816 |
| Device name | Quantium |
| Applicant | Bisco, Inc. |
| Product code | EBF |
| Device class | Class II |
| Decision date | Dec 17, 2024 |
| Decision | Substantially Equivalent |
| Regulation | 872.3690 |
Quantium is a light-cured, radiopaque, universal composite resin designed for tooth restoration. It is used for direct anterior and posterior restorations, core build-ups, splinting, and indirect restorations including inlays, onlays, and veneers. The device blends with tooth structure when used alone or in a layering technique.
Both Quantium and the predicate TrusFIL are methacrylate-based, radiopaque, light-cure pastes requiring a dental adhesive and available in syringe and unit-dose capsule formats. The key difference is that Quantium uses Ytterbium Fluoride as a filler, which is an industry-standard filler, whereas TrusFIL uses different fillers. All chemical components of Quantium are based on industry standard chemistry and are substantially equivalent in performance.
ISO 4049:2019 was used for nonclinical testing, including sensitivity to light, depth of cure, flexural strength, water sorption, shade/color stability, radiopacity, compressive strength, flexural modulus, and hardness after cure.
Quantium and TrusFIL are both methacrylate-based, radiopaque, light-cure universal composites with identical indications for use. Both require dental adhesive and come in syringe and unit-dose formats. Nonclinical testing demonstrated that Quantium performed equal to or better than the predicate and met ISO 4049:2019 requirements. The substitution of Ytterbium Fluoride filler does not change the intended use or fundamental performance characteristics, making Quantium substantially equivalent to TrusFIL.
View the full FDA submission: accessdata.fda.gov